Brexpiprazole
- Strength
- .5 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Ajanta Pharma USA Inc.
Not stocked by us — reference only
Listed by Ajanta Pharma USA Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | ANDA — approved generic |
| NDC code | 27241-209 |
| FDA application | ANDA213718 |
| RxNorm concept | 1658319 |
| Package sizes listed | 1 |
| Marketed since | February 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Ajanta Pharma USA Inc.
Not stocked by us — reference only
Ajanta Pharma USA Inc.
Not stocked by us — reference only
Ajanta Pharma USA Inc.
Not stocked by us — reference only
Ajanta Pharma USA Inc.
Not stocked by us — reference only
Ajanta Pharma USA Inc.
Not stocked by us — reference only
brexpiprazole
Otsuka America Pharmaceutical, Inc.
Not stocked by us — reference only
brexpiprazole
Otsuka America Pharmaceutical, Inc.
Not stocked by us — reference only
brexpiprazole
Otsuka America Pharmaceutical, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.